1. Home
  2. AIN vs BCRX Comparison

AIN vs BCRX Comparison

Compare AIN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Albany International Corporation

AIN

Albany International Corporation

HOLD

Current Price

$53.56

Market Cap

1.7B

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.21

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIN
BCRX
Founded
1895
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.1B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
AIN
BCRX
Price
$53.56
$8.21
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$60.25
$20.82
AVG Volume (30 Days)
285.4K
4.1M
Earning Date
06-01-2026
05-15-2026
Dividend Yield
2.05%
N/A
EPS Growth
N/A
381.40
EPS
N/A
1.21
Revenue
$1,054,132,000.00
$25,186,000.00
Revenue This Year
$2.89
N/A
Revenue Next Year
N/A
$12.55
P/E Ratio
N/A
$6.93
Revenue Growth
7.29
N/A
52 Week Low
$41.15
$6.00
52 Week High
$75.16
$11.31

Technical Indicators

Market Signals
Indicator
AIN
BCRX
Relative Strength Index (RSI) 36.55 57.26
Support Level $52.70 $7.95
Resistance Level $53.88 $8.68
Average True Range (ATR) 2.38 0.33
MACD -0.60 -0.01
Stochastic Oscillator 12.48 51.57

Price Performance

Historical Comparison
AIN
BCRX

About AIN Albany International Corporation

Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: